Are you active in non-alcoholic-steatohepatitis (NASH) research? Maybe you’re investigating blood biomarkers for a clinical diagnostic or disease monitoring assay? Maybe you’re interested in longitudinally studying patient populations with a specific co-morbidity or medical history? Or maybe you’d like to compare normal liver tissue with diseased tissue?
The MT Group has collected thousands of blood and FFPE tissue biospecimens across NASH stages for its customers over the years. A more recent capability is our developing access to fresh liver tissue (a significant challenge in today’s FibroScan world)!
MT Group was founded in 2003 on the belief that clinical metadata are the key to precision medicine and NASH is no different. We pride ourselves in delivering comprehensive information with each NASH case, such as pathology, co-morbidities, and response to therapy, to power our customers’ discoveries.